Edwards Lifesciences Corporation: operating_income
| Value | {"amount": 1534100000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | superseded |
| Entity | Edwards Lifesciences Corporation |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:01:16.898471+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2f761551-2338-4f5c-90d4-6fb6a7f4b371
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001099800-24-000004Retrieved: 2026-08-19T11:01:16.898471+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001099800/operating-income/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2f761551-2338-4f5c-90d4-6fb6a7f4b371
History
- no predecessors — first report